Medicine and Health

Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralizing antibodies in COVID-19 patients

C. M. Poh, G. Carissimo, et al.

This groundbreaking research identifies two immunodominant regions on the SARS-CoV-2 spike glycoprotein, revealing one region as SARS-CoV-2 specific near the receptor-binding domain and another as a potential pan-SARS target. Conducted by a team of experts, this study enhances our understanding of antibody-mediated neutralization, paving the way for improved therapies and vaccines.